L-Arginine and Antioxidant Diet Supplementation Partially Restores Nitric Oxide-Dependent Regulation of Phenylephrine Renal Vasoconstriction in Diabetics Rats

Journal of Renal Nutrition

Volumn 20, Issue 3, 2010, Pages 158-168

  Coronel, Israel ^a   Arellano Mendoza, Monica G ^a   del Valle Mondragon, Leonardo ^b   Vargas Robles, Hilda ^a   Castorena Torres, Fabiola ^a   Romo, Eunice ^a   Rios, Amelia ^a   Escalante, Bruno ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

5,6,7,8-TETRAHYDROBIOPTERIN; ALPHA TOCOPHEROL; ANTIOXIDANT; ARGININE; ASCORBIC ACID; BIOPTERIN; DOCOSAHEXAENOIC ACID; DRUG DERIVATIVE; ENZYME INHIBITOR; ICOSAPENTAENOIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TETRAHYDROBIOPTERIN; VASOCONSTRICTOR AGENT;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; DIABETIC NEPHROPATHY; DIET SUPPLEMENTATION; DRUG ANTAGONISM; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; VASCULARIZATION; VASOCONSTRICTION; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; ARGININE; ASCORBIC ACID; BIOPTERIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ENZYME INHIBITORS; KIDNEY; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VITAMIN E;

ANIMALIA; RATTUS;

EID: 77950953435     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2009.10.008     Document Type: Article

References (28)

1. Yamagishi S., and Imaizumi T. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des 11 (2005) 2279-2299
2. Bonora E., and Muggeo P.M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia 44 (2001) 2107-2114
3. Lesniewski L.A., Donato A.J., Behnke B.J., et al. Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension. Am J Physiol Heart Circ Physiol 294 (2008) H1840-H1850
4. Abebe W., and Mozaffari M.S. Vascular reactivity in glucose-intolerant rat. J Cardiovasc Pharmacol 50 (2007) 590-597
5. Abebe W., Harris K.H., and Macleod K.M. Enhanced contractile responses of arteries from diabetic rats to alpha 1-adrenoreceptor stimulation in the absence and presence of extracellular calcium. J Cardiovasc Pharmacol 16 (1990) 239-248
6. Shi Y., and Vanhoutte P.M. Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats. Br J Pharmacol 154 (2008) 639-651
7. Okon E.B., Chung A.W.Y., Rauniyar P., et al. Compromised arterial function in human type 2 diabetic patients. Diabetes 54 (2005) 2415-2423
8. Sartoretto J.L., Oliveira M.A., Nigro D., Carvalho M.H.C., Tostes R.C., and Fortes Z.B. Constrictor responses to noradrenalin, hemodynamic profile and superoxide levels measured by hydroethidine in diabetic rats. Biol Pharm Bull 30 (1938-1942) 2007
9. Sartoretto J.L., Melo G.A., Carvalho M.H., et al. Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression. Life Sci 77 (2005) 2676-2689
10. Evans J.L., Goldfine I.D., Maddux B.A., and Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23 (2002) 599-622
11. Tang E.H., Leung F.P., Huang Y., Feletou M., So K.F., and Man R.Y.K. Calcium and oxygen species increase in endothelial cells in response to release of endothelium-derived contracting factor. Br. J Pharmacol 151 (2007) 15-23
12. Tesch G.H., and Allen T.J. Rodent models of streptozotocin-induced nephropathy. Nephrology 12 (2007) 261-266
13. Levere R.D., Martasek P., Escalante B., et al. Effect of heme arginate administration on blood-pressure in spontaneously hypertensive rats. J Clin Invest 86 (1990) 213-219
14. Niu Tian K.D., Thrasher P.D., Gundy M.D., and Davis Manning R.D. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt sensitive hypertension. Hypertension 45 (2005) 934-939
15. Arellano-Mendoza M.G., Castillo-Henkel C., Medina-Santillan R., et al. Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase (-/-) mice and improved by combined administration of L-arginine and antioxidants. Nephrology 13 (2008) 218-227
16. Rothe G., and Valet G. Flow cytometric analysis of respiratory bursa activity in phagocytes which hydroethidine and 2′,7′-dichlorofluorescein. J Leukocyte Biol 55 (1995) 253-258
17. Heales S., and Hyland K. Determination of quinonoid dihydrobiopterin by high-performance liquid chromatography and electrochemical detection. J Chromatogr 494 (1989) 77-85
18. Sanchez-Mendoza A., Hong E., and Escalante B. The role of nitric oxide in angiotensin II-induced renal vasoconstriction in renovascular hypertension. J Hypertens 15 (1998) 697-703
19. Breyer M.D., Bottinger E., Brosius F.C., et al. Mouse models of diabetic nephropathy. J Am Soc Nephrol 16 (2005) 27-45
20. Scmezer P., Ecker C., and Liegibel U.M. Tissue-specific induction of mutations by streptozotocin in vivo. Mutat Res 307 (1994) 495-499
21. Inada A., Kanamori H., Arai H., et al. A model of diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse. J Cell Physiol 215 (2008) 383-391
22. Hebden R.A. Experimental models of diabetes. In: McNeill J.H. (Ed) (1999), CRC Press, Boca Raton 177-193
23. Esler M., Rumantir M., Wiesner G., Kaye D., Hastings J., and Lambert G. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens 14 Suppl. (2004) 304S-309S
24. Xiang L., Dearman J., Abram S.R., Carter C., and Hester R.L. Insulin resistance and impaired functional vasodilation in obese Zucker rats. Am J Physiol Heart Circ Physiol 294 (2008) H1658-H1666
25. Yagishashi N., Nishida N., Geuk S.H., Taniguchi N., and Yagihashi S. Expression of nitric oxide synthase in macula densa in streptozotocin diabetic rats. Diabetologia 39 (1996) 793-799
26. Cosenzi A., Bernobich E., Bonavita M., Trevisan R., Bellini G., and Campanacci L. Early effects of diabetes on inducible nitric oxide synthase in the kidney. Acta Diabetol Lat 39 (2002) 91-96
27. Guzik T.J., Mussa S., Gastaldi D., et al. Mechanism of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105 (2000) 1656-1662
28. Settergren M., Bohm F., Malmstrom R.E., Channon K.M., and Pernow J. L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease. Atheroesclerosis 204 (2009) 73-78